Insulin Resistance in Cognitive Impairment
Authors:
- Cristina GeroldiCGCristina Geroldi
- Giovanni B. FrisoniGFGiovanni B. Frisoni
- Giuseppe PaolissoGPGiuseppe Paolisso
- Stefania BandinelliSBStefania Bandinelli
- Marco LamponiMLMarco Lamponi
- Angela Marie AbbatecolaAAAngela Marie Abbatecola
- Orazio ZanettiOZOrazio Zanetti
- Jack M. GuralnikJGJack M. Guralnik
- Luigi FerrucciLFLuigi Ferrucci
Open Access
- 1 July 2005
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Neurology
- Vol. 62 (7) , 1067-1072
Abstract
Alzheimer disease (AD) is a primary degenerative dementia. A growing body of evidence, however, suggests that microvascular lesions might represent a co-occurring factor that both determines the onset1 and influences the clinical expression of AD.2This observation is supported by the recent description of several risk factors for AD, which are also well-known risk factors for cerebrovascular disease, including hypertension,3,4 hypercholesterolemia,5 coronary heart disease,6 atrial fibrillation,7 generalized atherosclerosis,8 and diabetes mellitus.9 Type 2 diabetes mellitus is particularly interesting, especially in the early stage, characterized by progressing insulin peripheral resistance and high fasting blood insulin levels, but normal fasting blood glucose levels. This condition is almost invariably associated with cardiovascular, metabolic, and endocrine disorders (such as systemic hypertension, obesity, elevated plasma triglycerides and total cholesterol levels, and decreased high-density lipoprotein cholesterol [HDL-C] levels), constituting the insulin resistance (IR) syndrome (also called syndrome X or the metabolic syndrome), which is a strong risk factor for ischemic cardiac events10 and stroke.10Keywords
This publication has 1 reference indexed in Scilit: